PharmAnalytics
Turning Pharma Data into Decisions
A comprehensive analytics platform that transforms pharma market data into actionable insights across sales, marketing, and supply chain.
16,000
Stockists on Panel
70%
IPM Coverage
30%
Extrapolation Only
PharmAnalytics is a comprehensive analytics platform that transforms pharma market data into actionable insights across sales, marketing, and supply chain.
Built on an extensive panel of 16,000 stockists representing 70% of the Indian Pharma Market, it enables pharma companies to understand market dynamics, optimize strategies, and drive better business outcomes. The extrapolation done is only 30%, which ensures robust data quality.
Core Problem
Pharma companies today operate in a data-rich but insight-poor environment.
Market data is fragmented across sources and systems
Limited visibility into market share, competition, and growth trends
Difficulty in understanding therapy shifts and product performance
Inefficient decision-making for portfolio, pricing, and targeting
Poor alignment between primary sales, secondary sales, and inventory
Lack of granular insights at regional and cluster levels
The result: missed opportunities, inefficient planning, and suboptimal market performance.
Client Engagements in PharmAnalytics Space
Three pillars of value delivered across pharma organisations.
Competitive Analysis
Market Rank, Market Share, Market Share Gain/Loss
Market Molecular Shift Analysis
Trends at different levels — Value, Units, Quantity
MAT, Quarter, Month
National, Regional (State & Clusters within States)
Growth, Evolution Index, Market Saliency
Data source: PharmaTrac & Market Pulse, City Cluster Audit, KPI Dashboards
Strategic Decision Making
Portfolio Optimization — Therapy presence, Molecular mix, New Products to Launch
Product Mix — Dosage forms, strengths, packs
Pricing
Headquarter Planning — Manpower allocation and productivity
Targeting — Headquarter + Outstation Clusters
Data source: PharmaTrac, Market Pulse, Optential
Operational Excellence
Bonus Offer Rationalization — Benchmark with Market offtake
Market Share impact
Inventory Corrections — Ensure availability, Evaluate fine balance between Market Push and Pull
Reduce stock issues in terms of returns / expiries
Stockist Selection based on potential and uptake
Data source: PharmaTrac, Market Pulse, Optipoint, PharmaTrac Weekly
Data Assets in Our PharmAnalytics Offerings
Comprehensive data capture across every dimension of the pharma value chain.
Pharma Company Details
Corporate · Company · Division
Product Details
Brand Name · Pack name · Strength · Pack Size · Pack Launch Date · NLEM 22
Mode of Delivery
Solid (Tablets, Capsules, Powders, Creams, Ointments) · Liquids (Solution, Suspension, Syrups) · Injectables (Injections, Vials, Pens, Pre-filled Syringes, Infusions)
Pricing Details
MRP – Maximum Retailer Price · PTR – Price to Retailer · PTS – Price to Stockist
Product Classification
20 Supergroups (Ephemra) → Subsupergroups based on usage → Subgroups based on molecules
Therapy Classification
Based on duration of Treatment or Prescription (Rx) — Acute (7–30 days) · Sub-chronic (1–6 months) · Chronic (6+ months)
Bonus Passout
Paid units vs free units and its impact on Market share
Inventory
Inventory Days = (Closing / Sales) × 30
Products Within PharmAnalytics
Each product delivers a distinct layer of market intelligence.
PharmaTrac
16,000 stockist panel · 70% IPM · 22-region granularity. Trusted by NPPA for pricing decisions.
Know More →Market Pulse
India's first Secondary Sales Audit · 16,000 stockists · 78-region granularity.
Know More →City Cluster Audit
Pin code level competitive intelligence (MS%) for core cities. Non-projected data from July 2024.
Know More →Strategy Tools
Optential (~1,200+ towns, census of ~30,000 stockists) + Optipoint (State-level stockist classification).
Know More →Ready to Turn Your Data into Decisions?
Talk to our team about a PharmAnalytics engagement tailored to your therapy areas and geographies.
Get in Touch